Cargando…
A New Therapy for Uncomplicated Vulvovaginal Candidiasis and Its Impact on Vaginal Flora
Background: An estimated 75% of women will have one episode of vulvovaginal candidiasis (VCC) during their lifetime, and 40–50% of these will experience further episodes. The high incidence of vulvovaginal candidiasis, combined with the problems of azole resistance and toxicity, highlights the neces...
Autores principales: | Stabile, Guglielmo, Gentile, Roberta Marie, Carlucci, Stefania, Restaino, Stefano, De Seta, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625853/ https://www.ncbi.nlm.nih.gov/pubmed/34828601 http://dx.doi.org/10.3390/healthcare9111555 |
Ejemplares similares
-
Diverse Vaginal Microbiomes in Reproductive-Age Women with Vulvovaginal Candidiasis
por: Liu, Mu-Biao, et al.
Publicado: (2013) -
Role of Vaginal Mucosa, Host Immunity and Microbiota in Vulvovaginal Candidiasis
por: Balakrishnan, Subatrra Nair, et al.
Publicado: (2022) -
Patient preferences and treatment safety for uncomplicated vulvovaginal candidiasis in primary health care
por: Del-Cura González, Isabel, et al.
Publicado: (2011) -
Distinct host immune responses in recurrent vulvovaginal candidiasis and vulvovaginal candidiasis
por: Ge, Gai, et al.
Publicado: (2022) -
Factors involved in patient choice of oral or vaginal treatment for vulvovaginal candidiasis
por: Sobel, Jack D
Publicado: (2013)